Selected article for: "vitro influenza virus replication inhibit and vivo vitro replication"
Author: Ciejka, Justyna; Botwina, Paweł; Nowakowska, Maria; Szczubiałka, Krzysztof; Pyrc, Krzysztof
Title: Synthetic sulfonated derivatives of poly(allylamine hydrochloride) as inhibitors of human metapneumovirus
  • Cord-id: jzfl4xuk
  • Document date: 2019_3_28
    • ID: jzfl4xuk
    Snippet: Human metapneumovirus (hMPV) is a widely distributed pathogen responsible for acute upper and lower respiratory infections of varying severity. Previously, we reported that N-sulfonated derivatives of poly(allylamine hydrochloride) (NSPAHs) efficiently inhibit replication of the influenza virus in vitro and ex vivo. Here, we show a dose dependent inhibition of hMPV infection by NSPAHs in LLC-MK2 cells. The results showed strong antiviral properties of NSPAHs. While the activity of NSPAHs is comp
    Document: Human metapneumovirus (hMPV) is a widely distributed pathogen responsible for acute upper and lower respiratory infections of varying severity. Previously, we reported that N-sulfonated derivatives of poly(allylamine hydrochloride) (NSPAHs) efficiently inhibit replication of the influenza virus in vitro and ex vivo. Here, we show a dose dependent inhibition of hMPV infection by NSPAHs in LLC-MK2 cells. The results showed strong antiviral properties of NSPAHs. While the activity of NSPAHs is comparable to those of carrageenans, they show better physicochemical properties and may be delivered at high concentrations. The functional assays showed that tested polymers block hMPV release from infected cells and, consequently, constrain virus spread. Moreover, further studies on viruses utilizing different egress mechanisms suggest that observed antiviral effect depend on selective inhibition of viruses budding from the cell surface.

    Search related documents:
    Co phrase search for related documents
    • absence presence and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • absence presence and log reduction: 1
    • absence presence and low concentration: 1, 2, 3
    • absence presence and lysis buffer: 1, 2, 3, 4, 5
    • action mechanism and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • action mechanism and log reduction: 1, 2
    • action mechanism and low concentration: 1, 2, 3, 4
    • acute infection and log reduction: 1, 2, 3
    • acute infection and low concentration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute infection and lysis buffer: 1
    • log reduction and low concentration: 1, 2
    • low concentration and lysis buffer: 1, 2